Dan S. Kaufman

12.1k total citations · 4 hit papers
168 papers, 8.6k citations indexed

About

Dan S. Kaufman is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Dan S. Kaufman has authored 168 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Molecular Biology, 74 papers in Immunology and 72 papers in Oncology. Recurrent topics in Dan S. Kaufman's work include Pluripotent Stem Cells Research (77 papers), CAR-T cell therapy research (67 papers) and Immune Cell Function and Interaction (66 papers). Dan S. Kaufman is often cited by papers focused on Pluripotent Stem Cells Research (77 papers), CAR-T cell therapy research (67 papers) and Immune Cell Function and Interaction (66 papers). Dan S. Kaufman collaborates with scholars based in United States, Sweden and Norway. Dan S. Kaufman's co-authors include James A. Thomson, David Hermanson, Jon S. Odorico, Ye Li, Branden S. Moriarity, David A. Knorr, Rachel L. Lewis, Robert Auerbach, Petter Woll and Xinghui Tian and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Nature Communications.

In The Last Decade

Dan S. Kaufman

159 papers receiving 8.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity

2018 748 citations David Hermanson, Branden S. Moriarity et al. Cell stem cell profile →
Multilineage Differentiation from Human Embryonic Stem Cell Lines

2001 687 citations Jon S. Odorico, Dan S. Kaufman et al. profile →
Hematopoietic colony-forming cells derived from human embryonic stem cells

2001 665 citations Dan S. Kaufman, James A. Thomson et al. profile →
Cardiac Repair in a Porcine Model of Acute Myocardial Infarction with Human Induced Pluripotent Stem Cell-Derived Cardiovascular Cells

2014 353 citations Pengyuan Zhang, Cory Swingen et al. Cell stem cell profile →

Peers

Countries citing papers authored by Dan S. Kaufman

Since Specialization

Citations

This map shows the geographic impact of Dan S. Kaufman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan S. Kaufman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan S. Kaufman more than expected).

Fields of papers citing papers by Dan S. Kaufman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan S. Kaufman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan S. Kaufman. The network helps show where Dan S. Kaufman may publish in the future.

Co-authorship network of co-authors of Dan S. Kaufman

This figure shows the co-authorship network connecting the top 25 collaborators of Dan S. Kaufman. A scholar is included among the top collaborators of Dan S. Kaufman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan S. Kaufman. Dan S. Kaufman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Disruption of TGF-β signaling pathway is required to mediate effective killing of hepatocellular carcinoma by human iPSC-derived NK cells 2024 ·Cell stem cell ·(unknown), Michael Coffey, Edith Lopez, Dan S. Kaufman	34
2	Metastatic gastric cancer target lesion complete response with Claudin18.2-CAR T cells 2024 ·Journal for ImmunoTherapy of Cancer ·Gregory P. Botta, Joseph Chao, H. Ma, Michael G. Hahn, Gloria Sierra, Jie Jia, (unknown), Joy Nolte Fong, (unknown), (unknown), Aaron Miller, Michael Y. Choi, Benjamin Heyman, Gregory A. Daniels, Dan S. Kaufman, Catriona Jamieson, Zonghai Li, Ezra E.W. Cohen	15
3	Engineering Superaffinity Antibody Dependent Cellular Cytotoxcity Receptors into iPSC-Derived NK Cells As Next-Generation Immunotherapies for Cancer 2023 ·Blood ·Spencer Goodman, (unknown), (unknown), (unknown), Qin Li, David R. Murray, (unknown), (unknown), (unknown), Guoxin Zhang, (unknown), Baohu Ji, (unknown), Dan S. Kaufman, (unknown), (unknown)	2
4	CHMP2A regulates tumor sensitivity to natural killer cell-mediated cytotoxicity 2022 ·Nature Communications ·Davide Bernareggi, Qi Xie, Briana C. Prager, (unknown), (unknown), Timothy V. Pham, William Kim, (unknown), Michael Coffey, Cristina Zalfa, Pardis Azmoon, Zhu Huang, Pablo Tamayo, Jeremy N. Rich, Dan S. Kaufman	46
5	Development of Chimeric Antigen Receptor-Expressing iPSC-Derived Macrophages with Improved Anti-Tumor Activity 2021 ·Blood ·Somayeh Pouyanfard, (unknown), Dan S. Kaufman	5
6	Genetically Engineered Pluripotent Cell-Derived Natural Killer Cell Therapy Provides Enhanced Antibody Dependent Cellular Cytotoxicity Against Hematologic Malignancies and Solid Tumors in Combination with Monoclonal Antibody Therapy 2017 ·Blood ·Zhu Huang, Ryan Bjordahl, Svetlana Gaidarova, Paul Rogers, Robert Blum, Dan S. Kaufman, Bruce Walcheck, Bahram Valamehr	3
7	Engineering Human Induced Pluripotent Stem Cells with Novel Chimeric Antigen Receptors to Generate Natural Killer (NK) Cell Cancer Immunotherapies with Targeted Anti-Tumor Activity 2017 ·Blood ·(unknown), David Hermanson, Branden S. Moriarity, Ryan Bjordahl, Sajid Mahmood, Bahram Valamehr, Dan S. Kaufman	1
8	Human pluripotent stem cell-derived natural killer cells for anti-cancer therapy 2016 ·Experimental Hematology ·Dan S. Kaufman	1
9	Heterodimeric Bispecific Single-Chain Variable-Fragment Antibodies Against EpCAM and CD16 Induce Effective Antibody-Dependent Cellular Cytotoxicity Against Human Carcinoma Cells 2013 ·Cancer Biotherapy and Radiopharmaceuticals ·Daniel A. Vallera, Bin Zhang, Michelle Gleason, Seunguk Oh, Louis M. Weiner, Dan S. Kaufman, Valarie McCullar, Jeffrey S. Miller, Michael R. Verneris	82
10	Engineered Human Embryonic Stem Cell-Derived Lymphocytes to Study In Vivo Trafficking and Immunotherapy 2013 ·Stem Cells and Development ·David A. Knorr, Allison M. Bock, Renier J. Brentjens, Dan S. Kaufman	21
11	Intraperitoneal delivery of human natural killer cells for treatment of ovarian cancer in a mouse xenograft model 2013 ·Cytotherapy ·Melissa A. Geller, David A. Knorr, (unknown), (unknown), Laura E. Bendzick, Valarie McCullar, Jeffrey S. Miller, Dan S. Kaufman	58
12	Abstract 16457: Transplantation of Human Induced Pluripotent Stem Cells Derived Cardiac Cells for Cardiac Repair 2012 ·Circulation ·Lei Ye, Qiang Xiong, Pengyuan Zhang, (unknown), Cory Swingen, Jianhua Zhang, Timothy J. Kamp, Dan S. Kaufman, Jianyi Zhang	2
13	Extramedullary Relapse of Acute Myelogenous Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: Better Prognosis Than Systemic Relapse 2011 ·Biology of Blood and Marrow Transplantation ·Melhem Solh, Todd E. DeFor, Daniel J. Weisdorf, Dan S. Kaufman	57
14	Differences in lymphocyte developmental potential between human embryonic stem cell and umbilical cord blood–derived hematopoietic progenitor cells 2008 ·Blood ·Colin H. Martin, Petter Woll, Zhenya Ni, Juan Carlos Zúñiga‐Pflücker, Dan S. Kaufman	52
15	Selective POTE Paralogs on Chromosome 2 are Expressed in Human Embryonic Stem Cells 2008 ·Stem Cells and Development ·Tapan K. Bera, (unknown), Duc Ha, M. Yamada, Yoomi Lee, Byung Kook Lee, Yoonsoo Hahn, Dan S. Kaufman, Martín F. Pera, Ira Pastan	17
16	Improved development of human embryonic stem cell‐derived embryoid bodies by stirred vessel cultivation 2006 ·Biotechnology and Bioengineering ·(unknown), Wei‐Shou Hu, Dan S. Kaufman	116
17	Human Embryonic Stem Cell-Derived NK Cells Acquire Functional Receptors and Cytolytic Activity 2005 ·The Journal of Immunology ·Petter Woll, Colin H. Martin, Jeffrey S. Miller, Dan S. Kaufman	176
18	Defined Conditions for Development of Functional Hepatic Cells from Human Embryonic Stem Cells 2005 ·Stem Cells and Development ·Robert E. Schwartz, Jonathan L. Linehan, Matthew Painschab, Wei‐Shou Hu, Catherine M. Verfaillie, Dan S. Kaufman	100
19	Transplantation Therapies from Human Embryonic Stem Cells—Circumventing Immune Rejection 2000 ·Dan S. Kaufman, Jon S. Odorico, James A. Thomson	2
20	Reversible central nervous system toxicity associated with high-dose chlorambucil in autologous bone marrow transplantation for ovarian carcinoma. 1987 ·PubMed ·N. Ciobanu, Carolyn D. Runowicz, Rasim Gucalp, (unknown), (unknown), Dan S. Kaufman, P H Wiernik	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact